Zimbabwe has rejected a substantial American health deal worth $367m (272 million pounds) over five years due to Washington's insistence on confidential information.
This rejection became public after a official document from December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesman later clarified that the United States was seeking biological samples for scientific study and commercial purposes while refused to share the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged more talks to secure a deal agreeable to both sides so the country's critical HIV treatment initiative can proceed.
Broader Context
This development follows a similar case in Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the safety of citizens' medical information.
After returning to the presidency last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
USAID had administered aid for the American government, but Trump stated its spending was "wasteful" and his government was seeking government-to-government agreements to boost openness and responsibility.
According to reports, 16 nations in Africa have to date agreed to these new health pacts, constituting more than $18.3bn in new funding.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy via US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to share its genetic material and health information over an extended period, without any equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that might result from that provided information," he stated.
"In essence, our country would supply the raw materials for scientific discovery without any certainty that the end products would be accessible to our citizens should a future pandemic emerge."
National Interest and Global Health
Mangwana further pointed out that the American exit from the global health body and its push of one-on-one health agreements were upending systems already established through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with future pandemics.
"This framework is intended to ensure that when a country contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We are open to continued discussions with our American counterparts on how future collaboration could be structured in a way that honours the sovereignty and dignity of both nations."
Medical Community Response
A leading public health body said it acknowledged the government's concerns, but suggested that talks need to persist since much of the nation's HIV programmes depended on external financing.
"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," the group said.
The situation highlights the complex debate between receiving crucial foreign assistance and safeguarding national sovereignty in an ever more data-driven world.